FDA rejects MDMA as psychedelic-based treatment for mental health, PTSD
The U.S. Food and Drug Administration (FDA) announced Friday its rejection of MDMA as a treatment for PTSD.The decision was based on “significant limitations” that “prevent the agency from concluding…